Gene-eluting stents: Comparison of adenoviral and adeno-associated viral gene delivery to the blood vessel wall in vivo

Human Gene Therapy

Volumn 17, Issue 7, 2006, Pages 741-750

  Sharif, Faisal ^a,b   Hynes, Sean O ^a,b   McMahon, Jill ^a,b   Cooney, Ronan ^a,b   Conroy, Siobhan ^a,b   Dockery, Peter ^a   Duffy, Garry ^a   Daly, Kieran ^b   Crowley, James ^b   Bartlett, Jeffrey S ^c   O'Brien, Timothy ^a,b  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b UNIVERSITY HOSPITAL GALWAY   (Ireland)

^c THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACEPROMAZINE; ADENOVIRUS VECTOR; BETA GALACTOSIDASE; HEPARIN; KETAMINE; LEPIRUDIN; PARVOVIRUS VECTOR; PHOSPHORYLCHOLINE; XYLAZINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTICLE; BALLOON DILATATION; BLOOD VESSEL WALL; COMPARATIVE STUDY; CONTROLLED STUDY; DEVICE; DISEASE MODEL; DRUG ELUTING STENT; GENE ELUTING STENT; GENE EXPRESSION; GENE TRANSFER; ILIAC ARTERY; IN-STENT RESTENOSIS; INTIMA; NONHUMAN; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ADENOVIRIDAE; ANIMALS; BETA-GALACTOSIDASE; BLOOD VESSELS; DEPENDOVIRUS; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; RABBITS; STENTS; TRANSGENES;

ADENO-ASSOCIATED VIRUS - 2; ADENOVIRIDAE; ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 33746218887     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2006.17.741     Document Type: Article

References (24)

1. AURICCHIO, A., BEHLING, K.C., MAGUIRE, A.M., O'CONNOR, E.M., BENNETT, J., WILSON, J.M., and TOLENTINO, M.J. (2002). Inhibition of retinal neovascularization by intraocular viral-mediated delivery of anti-angiogenic agents. Mol. Ther. 6, 490-494.
2. CHEN, S., KAPTURCZAK, M., LOILER, S.A., ZOLOTUKHIN, S., GLUSHAKOVA, O.Y., MADSEN, K.M., SAMULSKI, R.J., HAUSWIRTH, W.W., CAMPBELL-THOMPSON, M., BERNS, K.I., FLOTTE, T.R., ATKINSON, M.A., TISHER, C.C., and AGARWAL, A. (2005). Efficient transduction of vascular endothelial cells with recombinant adeno-associated virus serotype 1 and 5 vectors. Hum. Gene Ther. 16, 235-247.
3. CLARK, K.R., VOUGLGAROPOULOU, F., FRALEY, D.M., and JOHNSON, P.R. (1995). Cell lines for the production of recombinant adeno-associated virus. Hum. Gene Ther. 6, 1329-1341.
4. CLARK, K.R., LIU, X., MCGRATH, J.P., and JOHNSON, P.R. (1999). Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses. Hum. Gene Ther. 10, 1031-1039.
5. DUFFY, A.M., O'DOHERTY, A.M., O'BRIEN, T., and STRAPPE, P.M. (2005). Purification of adenovirus and adeno-associated virus: Comparison of novel membrane-based technology to conventional techniques. Gene Ther. 12(Suppl. 1), S62-S72.
6. GRUCHALA, M., BHARDWAJ, S., PAJUSOLA, K., ROY, H., RISSANEN, T.T., KOKINA, I., KHOLOVA, I., MARKKANEN, J.E., RUTANEN, J., HEIKURA, T., ALITALO, K., BUELER, H., and YLA-HERTTUALA, S. (2004). Gene transfer into rabbit arteries with adeno-associated virus and adenovirus vectors. J. Gene Med. 6, 545-554.
7. HACEIN-BEY-ABINA, S., VON KALLE, C., SCHMIDT, M., MCCORMACK, M.P., WULFFRAAT, N., LEBOULCH, P., LIM, A., OSBOURNE, C.S., PAWLIUK, R., MORILLON, E., SORENSEN, R., FORSTER, A., FRASER, P., COHEN, J.I., DE SAINT BASILE, G., ALEXANDER, I., WINTERGERST, U., FREBOURG, T., AURIAS, A., STOPPA-LYONNET, D., ROMANA, S., RADFORDWEISS, I., GROSS, F., VALENSI, F., DELABESSE, E., MACINTYRE, E., SIGUAX, F., SOULIER, J., LEIVA, L.E., WISSLER, M., PRINZ, C., RABBITTS, T.H., LE DEIST, F., FISCHER, A., and CAVAZZANA-CALVO, M. (2003). LMO2-assodated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302, 415-419.
8. HOFFMANN, R., MINTZ, G.S., DUSSAILLANT, G.R., POPMA, J.J., PICHARD, A.D., SATLER, L.F., KENT, K.M., GRIFFIN, J., and LEON, M.B. (1996). Patterns and mechanisms of instent restenosis: A serial intravascular ultrasound study. Circulation 94, 1247-1254.
9. JOHNSON, T.W., WU, Y.X., HERDEG, C., BAUMBACH, A., NEWBY, A.C., KARSCH, K.R., and OBERHOFF, M. (2005). Stent-based delivery of tissue inhibitor of metalloproteinase-3 adenovirus inhibits neointimal formation in porcine coronary arteries. Arterioscler. Thromb. Biol. 25, 754-759.
10. KLUGHERZ, B.D., JONES, P.L., CUI, X., CHEN, W., MENEVEAU, N.F., DEFELICE, s., CONNOLLY, J., WILENSKY, R.L., and LEVY, R.J. (2000). Gene delivery from a DNA controlled release stent in porcine coronary arteries. Nat. Biotechnol. 18, 1181-1184.
11. KLUGHERZ, B.D., SONG, C., DEFELICE, S., CUI, X., CONNOLLY, J., HINSON, J.T., WILENSKY, R.L., and LEVY, R.J. (2002) Gene delivery to pig coronary arteries from stents carrying antibody-tethered adenovirus. Hum. Gene Ther. 13, 443-454.
12. LEWIS, A.L., TOLHURST, L.A., and STRAFORD, P.W. (2002). Analysis of a phosphorylcholine based polymer coating on a coronary stent pre and post implantation. Biomaterials 23, 1697-1706.
13. LYNCH, C.M., HARA, P.S., LEONARD, J.C., WILLIAMS, J.K., DEAN, R.H., and GEARY, R.L. (1997) Adeno-associated virus vectors for vascular gene delivery. Circ. Res. 80, 497-505.
14. NEWMAN, K.D., DUNN, P.F., OWENS, J.W., SCHULICK, A.H., VIRMANI, R., SUKHOVA, G., LIBBY, P., and DICHEK, D.A. (1995). Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation and neointimal hyperplasia. J. Clin. Invest. 96, 2955-2965.
15. NITTA, Y., KAWAMOTO, S., HALBERT, C., IWATA, A., MILLER, A.D., MIYAZAKI, J., and ALLEN, M.D. (2005). A CMV-actin-globin hybrid promoter improves adeno-associated viral vector gene expression in the arterial wall in vivo. J. Gene Med. 7, 1348-1355.
16. PERLSTEIN, I., CONNOLLY, J.M., CUI, X., SONG, C., LI, Q., JONES, P.L., LU, Z., DEFELICE, S., KLUGHERZ, B., WILENSKY, R., and LEVY, R.J. (2003). DNA delivery from an intravascular stent with a denatured collagen-polylactic- polyglycolic acid-controlled release coating: Mechanism of enhanced transfection. Gene Ther. 10, 1420-1428.
17. ROLLING, F., NONG, Z., PISVIN, S., and COLLEN, D. (1997). Adeno-associated virus-mediated gene transfer into rat carotid arteries. Gene Ther. 4, 757-761.
18. SCHULICK, A.H., VASSALLI, G., DUNN, P.P., DONG, G., RADE, J.J., ZAMARRON, C., and DICHEK, D.A. (1997). Established immunity precludes adenovirus-mediated gene transfer in rat carotid arteries: Potential for immunosuppression and vector engineering to overcome barriers of immunity. J. Clin. Invest. 99, 209-219.
19. SEN, S., BARTLETT, J.S., AKTAR, Y., and O'BRIEN, T. (2003). Effect of adeno-associated virus serotype on vascular gene delivery in vivo. Circulation 108(Suppl. 4).
20. TAKAHASHI, A., PALMER-OPOLSKI, M., SMITH, R.C., and WALSH, K. (2003). Transgene delivery of plasmid DNA to smooth muscle cells and macrophages from a biostable polymer coated stents. Gene Ther. 10, 1471-1478.
21. WALTER, D.H., CEJNA, M., DIAZ-SANDOVAL, L., WILLIS, S., KIRKWOOD, L., STRATFORD, P.W., TIETZ, A.B., KIRCMAIR, R., SILVER, M., CURRY, C., WECKER, A., YOON, Y.S., HEIDENREICH, R., HANLEY, A., KEARNEY, M., TIO, F.O., KUENZLER, P., ISNER, J.M., and LOSARDO, D.W. (2004). Local gene transfer of VEGF-2 plasmid by gene-eluting stents: An alternative strategy for inhibition of restenosis. Circulation 110, 36-45.
22. WEN, S., GRAF, S., MASSEY, P.G., and DICHEK, D.A. (2004). Improved vascular gene transfer with a helper-dependent adenoviral vector. Circulation 110, 1484-1491.
23. WU, Y.X., JOHNSON, T., HERDEG, C., BAUMBACH, A., NEWBY, A.C., KARSCH, K.K., and OBERHOFF, M. (2003). Stent based local delivery of therapeutic adenovirus effectively reduces neointimal proliferation in porcine coronaries. Di Yi Jun Yi Da Xue Xue Bao 23, 1263-1265.
24. YANG, Y., NUNES, F.A., BERENCSI, K., FURTH, E.E., GONCZOL, E., and WILSON, J.M. (1994). Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. U.S.A. 91, 4407-4411.